Literature DB >> 17182041

Involvement of a Rho-ROCK-JNK pathway in arsenic trioxide-induced apoptosis in chronic myelogenous leukemia cells.

Sophie Potin1, Jacques Bertoglio, Jacqueline Bréard.   

Abstract

The apoptotic signals activated by As(2)O(3) in the chronic myelogenous leukemia (CML) cell lines K562 and KCL22 were investigated. As(2)O(3) was found to induce apoptosis in these cells via the intrinsic pathway. As(2)O(3) also induced a sustained c-Jun NH2-terminal kinase (JNK) activation which preceded and was necessary for caspase-9 activation. We established that Rho and its effector, the kinase ROCK, are activated by As(2)O(3). Inhibition of either Rho or ROCK prevented JNK activation and protected against apoptosis. Thus, in CML cells, apoptosis induced by As(2)O(3) is mediated, at least in part, via a Rho-ROCK-JNK axis. These findings define a novel signaling pathway for As(2)O(3)-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17182041     DOI: 10.1016/j.febslet.2006.12.016

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

1.  Pharmacological inhibition of Rho-kinase (ROCK) signaling enhances cisplatin resistance in neuroblastoma cells.

Authors:  Catharine A Street; Alissa A Routhier; Carrie Spencer; Ashley L Perkins; Katherine Masterjohn; Alexander Hackathorn; John Montalvo; Emily A Dennstedt; Brad A Bryan
Journal:  Int J Oncol       Date:  2010-11       Impact factor: 5.650

2.  ROCK mediates phorbol ester-induced apoptosis in prostate cancer cells via p21Cip1 up-regulation and JNK.

Authors:  Liqing Xiao; Masumi Eto; Marcelo G Kazanietz
Journal:  J Biol Chem       Date:  2009-08-10       Impact factor: 5.157

3.  Assessment of the involvement of oxidative stress and Mitogen-Activated Protein Kinase signaling pathways in the cytotoxic effects of arsenic trioxide and its combination with sulindac or its metabolites: sulindac sulfide and sulindac sulfone on human leukemic cell lines.

Authors:  M Stępnik; M Ferlińska; A Smok-Pieniążek; D Gradecka-Meesters; J Arkusz; M Stańczyk
Journal:  Med Oncol       Date:  2011-04-27       Impact factor: 3.064

4.  Polychlorinated biphenyls (PCBs) enhance metastatic properties of breast cancer cells by activating Rho-associated kinase (ROCK).

Authors:  Sijin Liu; Shitao Li; Yuguo Du
Journal:  PLoS One       Date:  2010-06-23       Impact factor: 3.240

5.  Cellular and molecular alterations induced by low‑dose fisetin in human chronic myeloid leukemia cells.

Authors:  Anna Klimaszewska-Wiśniewska; Dariusz Grzanka; Paulina Czajkowska; Marta Hałas-Wiśniewska; Justyna Durślewicz; Paulina Antosik; Alina Grzanka; Maciej Gagat
Journal:  Int J Oncol       Date:  2019-10-02       Impact factor: 5.650

6.  Esterase D and gamma 1 actin level might predict results of induction therapy in patients with acute myeloid leukemia without and with maturation.

Authors:  Maciej Kaźmierczak; Magdalena Luczak; Krzysztof Lewandowski; Luiza Handschuh; Anna Czyż; Małgorzata Jarmuż; Michał Gniot; Michał Michalak; Marek Figlerowicz; Mieczysław Komarnicki
Journal:  Med Oncol       Date:  2013-10-02       Impact factor: 3.064

7.  Identification of a novel anoikis signalling pathway using the fungal virulence factor gliotoxin.

Authors:  Florian Haun; Simon Neumann; Lukas Peintner; Katrin Wieland; Jüri Habicht; Carsten Schwan; Kristine Østevold; Maria Magdalena Koczorowska; Martin Biniossek; Matthias Kist; Hauke Busch; Melanie Boerries; Roger J Davis; Ulrich Maurer; Oliver Schilling; Klaus Aktories; Christoph Borner
Journal:  Nat Commun       Date:  2018-08-30       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.